#Japan

Regenerative Medicine Milestone: Japan Approves World's First Reprogrammed Human Cell Therapy

Japan has granted the world's first commercial approvals for medical products based on reprogrammed human cells (iPS cells), bringing a Nobel-winning discovery to the mass market. This regulatory milestone paves the way for advanced regenerative therapies for degenerative diseases. The decision highlights Japan's leadership in the field and is expected to accelerate global cell therapy adoption.

Williams·Mar 15, 2026